Physician profile
Daniel Depietro
NPI 1356872428
$4,488.23
in general payments reported to CMS, 2019-2025
11 companies · $2,553 in 2025
The $2,553 reported for 2025 was more than what 78% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,381 · 2024: $554 · 2025: $2,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,915 · Travel and Lodging: $1,023 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,915.03 |
| Travel and Lodging | $1,023.20 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $1,616.88 | 2025 | Lipiodol |
| Boston Scientific Corporation | $845.44 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Cryoablation Needles |
| Medical Templates Ag | $550.00 | 2023 | |
| Trisalus Life Sciences, INC. | $338.27 | 2025 | Trinav Infusion System |
| Balt USA, LLC | $269.24 | 2023 | Prestige Coil System |
| Cook Medical LLC | $247.04 | 2023 | Zilver Ptx |
| Sirtex Medical INC | $195.93 | 2023 | Sir-Spheres Microspheres |
| Delcath Systems | $161.18 | 2025 | Hepzato Kit |
| Abk Biomedical USA, INC. | $122.83 | 2025 | Eye90 Microspheres |
| Siemens Medical Solutions USA, INC. | $118.65 | 2023 | Artis Q Floor, Artis Icono Floor |
| Instylla, INC. | $22.77 | 2024 | Instylla Microcatheter, Instylla Delivery Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Depietro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.